In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

Using a trademark in different form than registered and proofs of genuine use – part 2

The First Board of Appeal of the European Union Intellectual Property Office (EUIPO) presented its Czytaj dalej

Validation, a short guide part II – How to perform validation?

Validation is, to put it simply, an activation of the right of protection for a patent Czytaj dalej

PATPOL IP RUNNERS once again at the start and finish line of POLAND BUSINESS RUN!

A Patpol and Patpol Legal running team composed of: Aleksandra Sołyga-Żurek, Anna Wiśniewska, Dariusz Piróg, Czytaj dalej